The finding of significant changes to TNF/TNFR signalling pathways at the bulk transcript level when comparing all MS cases to controls, which then were shown to vary according to the level of meningeal inflammation, provides further confirmation of a major role for TNF in the genesis of cortical pathology in MS. The gene discussed is TNF; the disease is myeloid sarcoma.